MCE - Delayed Quote EUR

Prim, S.A. (PRM.MC)

11.30
+0.10
+(0.89%)
At close: June 10 at 5:35:27 PM GMT+2
Loading Chart for PRM.MC
  • Previous Close 11.20
  • Open 11.20
  • Bid 11.20 x --
  • Ask 11.55 x --
  • Day's Range 11.15 - 11.70
  • 52 Week Range 9.06 - 12.10
  • Volume 512
  • Avg. Volume 7,348
  • Market Cap (intraday) 192.234M
  • Beta (5Y Monthly) 0.51
  • PE Ratio (TTM) 17.66
  • EPS (TTM) 0.64
  • Earnings Date Apr 29, 2025
  • Forward Dividend & Yield 0.22 (1.96%)
  • Ex-Dividend Date Mar 11, 2025
  • 1y Target Est 16.75

Prim, S.A. provides health technology, mobility, and health care products in Spain. The company offers collar, clavicle, armsling, hand and finger, shoulder, elbow, and wrist products. Its lower limbs products include calf brace, thigh, hip, knee, ankle, and foot related products. The company provides shoulder and back supports, bands, corsets, hyperextension braces, and thoracic protectors under the airtex PRO, bruxi calm, fisionprim, ORTHOPrim, PRIMcare, respira PLUS, airMed, airtex, AirTex breathable, aqtivo skin, aqtivo sport, comforGel, comforGel Lady, comforSil, ESSENCIAL, mottio sport range, my PRIM Kids, Neoprair, ONE SIZE, Primespine, and OLIUM brand names. It operates PrimAcademy, an offline and digital training platform. The company was founded in 1870 and is headquartered in Móstoles, Spain.

www.prim.es

958

Full Time Employees

December 31

Fiscal Year Ends

Recent News: PRM.MC

View More

Performance Overview: PRM.MC

Trailing total returns as of 6/10/2025, which may include dividends or other distributions. Benchmark is IBEX 35... (^IBEX) .

YTD Return

PRM.MC
18.23%
IBEX 35... (^IBEX)
23.27%

1-Year Return

PRM.MC
12.21%
IBEX 35... (^IBEX)
25.22%

3-Year Return

PRM.MC
12.34%
IBEX 35... (^IBEX)
69.49%

5-Year Return

PRM.MC
42.56%
IBEX 35... (^IBEX)
85.56%

Compare To: PRM.MC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PRM.MC

View More

Valuation Measures

Annual
As of 6/9/2025
  • Market Cap

    190.53M

  • Enterprise Value

    195.28M

  • Trailing P/E

    17.50

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.82

  • Price/Book (mrq)

    1.48

  • Enterprise Value/Revenue

    0.84

  • Enterprise Value/EBITDA

    7.44

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.68%

  • Return on Assets (ttm)

    4.48%

  • Return on Equity (ttm)

    8.57%

  • Revenue (ttm)

    233.36M

  • Net Income Avi to Common (ttm)

    10.92M

  • Diluted EPS (ttm)

    0.64

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    14.16M

  • Total Debt/Equity (mrq)

    14.35%

  • Levered Free Cash Flow (ttm)

    11.86M

Research Analysis: PRM.MC

View More

Company Insights: PRM.MC

Research Reports: PRM.MC

View More

People Also Watch